The medical workers involved in the vaccination process against COVID-19 were trained in the correct distribution, storage and administration of the Janssen / Johnson & Johnson vaccine, which was received on July 12 this year. Issues related to monitoring post-immunization events and vaccination data were also discussed.
The training took place in an online workshop, organized by the Ministry of Health, Labor and Social Protection and the National Agency for Public Health, with the support of the World Health Organization.
The training workshop was attended by representatives of all vaccination centers in the country, the management of MSMPS, as well as specialists from WHO, ANSP and USMF N. Testemitanu.
“Training of medical workers on the correct administration, storage and monitoring of vaccines that arrive in the Republic of Moldova is vital for the efficient conduct of the vaccination process. The safety of the citizens depends on this, but also the results of the vaccination campaign. We thank the external partners for the support provided, but also the medical workers for the enormous effort in this difficult period “, said the Secretary of State of MSMPS, Tatiana Zatîc.
The Janssen / Johnson & Johnson vaccine is produced by the American pharmaceutical company Johnson & Johnson to prevent COVID-19 virus infection. The vaccine is given intramuscularly with a single dose and is recommended for people at least 18 years of age. Following clinical trials, an efficacy of 66.3% was found against all forms of the disease and 100% against hospitalization caused by COVID-19. To date, more than 20 million doses of Janssen / Johnson & Johnson vaccine have been administered worldwide.
The Johnson & Johnson COVID-19 vaccine has been approved for use by the European Medicines Agency and is recommended by the Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA).
Yesterday, July 12, the Republic of Moldova received a batch of 151,200 doses of Johnson & Johnson vaccine, produced in the USA and delivered through the COVAX platform. The doses are to be distributed proportionally in all vaccination points in our country. It should be noted that a total batch of 518,000 Janssen / Johnson & Johnson vaccines will arrive in our country.
Since the beginning of the vaccination campaign, 803,049 doses of COVID-19 vaccine have been administered.
–
